Edward M Newman

Years Active: 2019-2019
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Thehang Luu, Paul Frankel, Jan H Beumer, Dean Lim, Mihaela Cristea, Leonard J Appleman, Heinz J Lenz, David R Gandara, Brian F Kiesel, Richard L Piekarz, Edward M Newman
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial. Cancer chemotherapy and pharmacology 84 (6) (2019)
Tanya Siddiqi, Paul Frankel, Jan H Beumer, Brian F Kiesel, Susan Christner, Chris Ruel, Joo Y Song, Robert Chen, Kevin R Kelly, Sikander Ailawadhi, Paul Kaesberg, Leslie Popplewell, Sandrine Puverel, Richard Piekarz, Stephen J Forman, Edward M Newman
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies. Leukemia & lymphoma 61 (2) (2019)

Edward M Newman.css-eqlu8i{font-size:small;padding-left:4px;}